| Description | IKZF5 Human Pre-designed siRNA Set A contains three designed siRNAs for IKZF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components IKZF5 siRNA-1: 5 nmol (HPLC) IKZF5 siRNA-2: 5 nmol (HPLC) IKZF5 siRNA-3: 5 nmol (HPLC) siRNA Negative Control:IKZF5 Human Pre-designed siRNA Set A contains three designed siRNAs for IKZF5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control. Components IKZF5 siRNA-1: 5 nmol (HPLC) IKZF5 siRNA-2: 5 nmol (HPLC) IKZF5 siRNA-3: 5 nmol (HPLC) siRNA Negative Control: 5 nmol (HPLC) FAM-labeled siRNA Negative Control: 5 nmol (HPLC) GAPDH siRNA Positive Control:5 nmol (HPLC)... Read More | Amyloid β-Protein Fragment 25-35 (Aβ25-35) is derived from the amyloid-β protein.amyloid-β protein, which is mapped to human chromosome 21q21.Aβ25-35 lacks the N-terminal domain and the metal binding site and is majorly generated by proteolytic cleavage of Aβ(1−40Amyloid β-Protein Fragment 25-35 (Aβ25-35) is derived from the amyloid-β protein.amyloid-β protein, which is mapped to human chromosome 21q21.Aβ25-35 lacks the N-terminal domain and the metal binding site and is majorly generated by proteolytic cleavage of Aβ(1−40) peptides. It has a β-sheet and β-turn structure. Amino Acid Sequence Gly-Ser-Asn-Lys-Gly-Ala-Ile-Ile-Gly-Leu-MetFunctional domain of Aβ required for both neurotrophic and neurotoxic effects... Read More | The Leuconostoc GPDH exhibits dual coenzyme specificity, namely NAD and NADP (Olive and Levy, Biochem., 6, 730 730, 1967). When assayed under conditions that are optimal for the particular coenzyme, the ratio of observed catalytic activity is NAD/NADP = 1.8 | Inquire | Purity>95% SDS-PAGEFunctionLipid transport protein in adipocytes. Binds both long chain fatty acids and retinoic acid. Delivers long-chain fatty acids and retinoic acid to their cognate receptors in the nucleus |